{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:45:21Z","timestamp":1794750321510,"version":"4.9.1"},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,1,4]],"date-time":"2002-01-04T00:00:00Z","timestamp":1010102400000},"content-version":"vor","delay-in-days":1130,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1998,12]]},"abstract":"<jats:p>We report the identification in five patients (three families) affected with type 2B von Willebrand disease (VWD) of three heterozygous nucleotide substitutions at the codon for arginine 543, 545 and 578 of the mature von Willebrand factor (VWF) subunit resulting in a glutamine, proline and leucine substitution, respectively. These mutations are located in the A1 loop where prevalent type 2B mutations (Arg543Trp, Arg545Cys and Arg578Gln) have been already identified at the same positions. By <jats:italic>in vitro<\/jats:italic> mutagenesis of full\u2010length cDNA of VWF and transient expression in Cos\u20107 cells, we have shown that the six corresponding mutated recombinant VWFs (Gln543, Trp543, Cys545, Pro545, Leu578 and Gln578 rVWF) exhibited quantitatively normal expression and normal multimeric pattern but increased ristocetin\u2010 and botrocetin\u2010induced binding to platelets as compared with that for wild\u2010type rVWF. The two mutations at position 545 induced the greatest reactivity for GPIb of corresponding rVWFs as compared to the two mutations at positions 543 and 578.<\/jats:p>","DOI":"10.1046\/j.1365-2141.1998.01040.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:07:02Z","timestamp":1047362822000},"page":"877-884","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Identification of new type 2B von Willebrand disease mutations: Arg543Gln, Arg545Pro and Arg578Leu"],"prefix":"10.1111","volume":"103","author":[{"given":"L.","family":"Hilbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gaucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F.","family":"Abgrall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Parquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Trzeciak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mazurier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(84)90081-3"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsb0398-189"},{"key":"e_1_2_6_4_2","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood.V78.9.2310.2310","article-title":"The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin and collagen and resides between amino acid residues Leu512 and Lys673","volume":"78","author":"Christophe O.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V87.6.2322.bloodjournal8762322","article-title":"Comparison analysis of type 2B von Willebrand disease mutations: implications for the mechanism of von Willebrand factor binding to platelets","volume":"87","author":"Cooney K.A.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.10.3793"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.17.10396"},{"key":"e_1_2_6_8_2","first-page":"1734","article-title":"A heparin\u2010binding domain of human von Willebrand factor","volume":"262","author":"Fujimura Y.","year":"1987","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_6_9_2","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V84.4.1024.1024","article-title":"Characterization of von Willebrand factor gene defects in two unrelated patients with type IIC von Willebrand disease","volume":"84","author":"Gaucher C.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_10_2","first-page":"177","article-title":"Von Willebrand disease: a database of point mutations, insertions and deletions","volume":"69","author":"Ginsburg D.","year":"1992","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1182\/blood.V83.6.1542.1542","article-title":"Leu 697\u2003\u2192\u2003Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease","volume":"83","author":"Hilbert L.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05423.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1055\/s-0038-1649725","article-title":"Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding: studies with recombinant von Willebrand factor","volume":"70","author":"Inbal A.","year":"1993","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.6.2032"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi9610313"},{"key":"e_1_2_6_16_2","first-page":"18","article-title":"Dosage de l'antig\u00e8ne li\u00e9 au facteur VIII par la technique ELISA: int\u00e9r\u00eat dans l'\u00e9tude de la maladie de Willebrand","volume":"25","author":"Mazurier C.","year":"1977","journal-title":"Pathologie et Biologie"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0038-1661448","article-title":"Improved characterization of plasma von Willebrand factor heterogeneity when using 2.5% agarose gel electrophoresis","volume":"55","author":"Mazurier C.","year":"1986","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/19.17.4800"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00374a004"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1182\/blood.V60.6.1453.1453","article-title":"Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von Willebrand factor","volume":"60","author":"Ruggeri Z.M.","year":"1982","journal-title":"Blood"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198005083021902"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109795"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler J.E.","year":"1994","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112064"},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"18172","DOI":"10.1016\/S0021-9258(18)55251-0","article-title":"Identification of discontinuous von Willebrand sequences involved in complex formation with Botrocetin: a model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib","volume":"266","author":"Sugimoto M.","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0021-9258(18)32879-5","article-title":"Biosynthesis of von Willebrand protein by human endothelial cells; identification of a large precursor polypeptide chain","volume":"258","author":"Wagner D.D.","year":"1983","journal-title":"Journal of Biological Chemistry"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.01040.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.01040.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1998.01040.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T00:25:21Z","timestamp":1698452721000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.1998.01040.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["10.1046\/j.1365-2141.1998.01040.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.1998.01040.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]},"assertion":[{"value":"2002-01-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}